Neutrophils in Tissue Injury and Repair: Molecular Mechanisms and Therapeutic Targets

Abstract

Tissue repair represents a highly intricate and ordered dynamic process, critically reliant on the orchestration of immune cells. Among these, neutrophils, the most abundant leukocytes in the body, emerge as the initial immune responders at injury sites. Traditionally recognized for their antimicrobial functions in innate immunity, neutrophils now garner attention for their indispensable roles in tissue repair. This review delves into their novel functions during the early stages of tissue injury. We elucidate the mechanisms underlying neutrophil recruitment and activation following tissue damage and explore their contributions to vascular network formation. Furthermore, we investigate the pivotal role of neutrophils during the initial phase of repair across different tissue types. Of particular interest is the investigation into how the fate of neutrophils influences overall tissue healing outcomes. By shedding light on these emerging aspects of neutrophil function in tissue repair, this review aims to pave the way for novel strategies and approaches in future organ defect repair, regeneration studies, and advancements in tissue engineering. The insights provided here have the potential to significantly impact the field of tissue repair and regeneration.

Keywords

neutrophils / polarization / angiogenesis / tissue repair / neutrophils fate

References

[1] J. Zarubova, M. M. Hasani-Sadrabadi, R. Ardehali, and S. Li, “Immunoengineering Strategies to Enhance Vascularization and Tissue Regeneration,” Advanced Drug Delivery Reviews 184 (2022): 114233.

[2] L. C. Shanley, O. R. Mahon, D. J. Kelly, and A. Dunne, “Harnessing the Innate and Adaptive Immune System for Tissue Repair and Regeneration: Considering More Than Macrophages,” Acta Biomaterialia 133 (2021): 208-221.

[3] A. Mantovani, M. A. Cassatella, C. Costantini, and S. Jaillon, “Neutrophils in the Activation and Regulation of Innate and Adaptive Immunity,” Nature Reviews Immunology no. 8 (2011): 519-531.

[4] T. A. Wilgus, S. Roy, and J. C. McDaniel, “Neutrophils and Wound Repair: Positive Actions and Negative Reactions,” Advances in Wound Care 2, no. 7 (2013): 379-388.

[5] M. Peiseler and P. Kubes, “More Friend Than Foe: The Emerging Role of Neutrophils in Tissue Repair,” Journal of Clinical Investigation 129, no. 7 (2019): 2629-2639.

[6] E. Kolaczkowska and P. Kubes, “Neutrophil Recruitment and Function in Health and Inflammation,” Nature Reviews Immunology 13, no. 3 (2013): 159-175.

[7] M. Phillipson and P. Kubes, “The Healing Power of Neutrophils,” Trends in Immunology 40, no. 7 (2019): 635-647.

[8] B. Cai, D. Lin, Y. Li, et al., “N2-Polarized Neutrophils Guide Bone Mesenchymal Stem Cell Recruitment and Initiate Bone Regeneration: A Missing Piece of the Bone Regeneration Puzzle,” Advanced Science (2021): e2100584. - 2198-3844 (Electronic).

[9] K. Ley, “Integration of Inflammatory Signals by Rolling Neutrophils,” Immunological Reviews 186 (2002): 8-18.

[10] E. Kolaczkowska and P. Kubes, “Neutrophil Recruitment and Function in Health and Inflammation,” Nature Reviews Immunology 13, no. 3 (2013): 159-175.

[11] Y. Li, X. Xu, H. J. Wang, et al., “Endoplasmic Reticulum Protein 72 Regulates Integrin Mac-1 Activity to Influence Neutrophil Recruitment,” Arteriosclerosis, Thrombosis, and Vascular Biology (2024).

[12] W.-Y. Lee and P. Kubes, “Leukocyte Adhesion in the Liver: Distinct Adhesion Paradigm From Other Organs,” Journal of Hepatology 48, no. 3 (2008): 504-512.

[13] B. G. Yipp, J. H. Kim, R. Lima, et al., “The Lung Is a Host Defense Niche for Immediate Neutrophil-Mediated Vascular Protection,” Science Immunology 2, no. 10 (2017).

[14] G. Andonegui, C. S. Bonder, F. Green, et al., “Endothelium-derived Toll-Like Receptor-4 Is the Key Molecule in LPS-induced Neutrophil Sequestration Into Lungs,” Journal of Clinical Investigation 111, no. 7 (2003): 1011-1020.

[15] S. R. Choudhury, L. Babes, J. J. Rahn, et al., “Dipeptidase-1 Is an Adhesion Receptor for Neutrophil Recruitment in Lungs and Liver,” Cell 178, no. 5 (2019): 1205-1221.

[16] K. Futosi, S. Fodor, and A. Mocsai, “Reprint of Neutrophil Cell Surface Receptors and Their Intracellular Signal Transduction Pathways,” International Immunopharmacology 17, no. 4 (2013): 1185-1197.

[17] K. Pittman and P. Kubes, “Damage-associated Molecular Patterns Control Neutrophil Recruitment,” Journal of Innate Immunity 5, no. 4 (2013): 315-323.

[18] X. Liu, B. Lu, J. Fu, X. Zhu, E. Song, and Y. Song, “Amorphous Silica Nanoparticles Induce Inflammation via Activation of NLRP3 Inflammasome and HMGB1/TLR4/MYD88/NF-kb Signaling Pathway in HUVEC Cells,” Journal of Hazardous Materials 404 (2021): 124050, Pt B.

[19] K. Matsushima, D. Yang, and J. J. Oppenheim, “Interleukin-8: An Evolving Chemokine,” Cytokine 153 (2022): 155828.

[20] E. Latz, T. S. Xiao, and A. Stutz, “Activation and Regulation of the Inflammasomes,” Nature Reviews Immunology 13, no. 6 (2013): 397-411.

[21] B. McDonald, K. Pittman, G. B. Menezes, et al., “Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation,” Science 330, no. 6002 (2010): 362-366.

[22] M. De Giovanni, H. Tam, C. Valet, Y. Xu, M. R. Looney, and J. G. Cyster, “GPR35 promotes Neutrophil Recruitment in Response to Serotonin Metabolite 5-HIAA,” Cell 185, no. 5 (2022): 815-830.

[23] S. de Oliveira, E. E. Rosowski, and A. Huttenlocher, “Neutrophil Migration in Infection and Wound Repair: Going Forward in Reverse,” Nature Reviews Immunology 16, no. 6 (2016): 378-391.

[24] F. Veglia, E. Sanseviero, and D. I. Gabrilovich, “Myeloid-derived Suppressor Cells in the Era of Increasing Myeloid Cell Diversity,” Nature Reviews Immunology 21, no. 8 (2021): 485-498.

[25] G. Wigerblad and M. J. Kaplan, “Neutrophil Extracellular Traps in Systemic Autoimmune and Autoinflammatory Diseases,” Nature Reviews Immunology 23, no. 5 (2023): 274-288.

[26] E. Nolan and I. Malanchi, “Connecting the Dots: Neutrophils at the Interface of Tissue Regeneration and Cancer,” Seminars In Immunology 57 (2021): 101598.

[27] A. R. Huber, S. L. Kunkel, R. F. Todd,, and S. J. Weiss, “Regulation of Transendothelial Neutrophil Migration by Endogenous Interleukin-8,” Science 254, no. 5028 (1991): 99-102.

[28] L. M. Webb, M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot, “Binding to Heparan Sulfate or Heparin Enhances Neutrophil Responses to Interleukin 8,” PNAS 90, no. 15 (1993): 7158-7162.

[29] A. Sparmann and D. Bar-Sagi, “Ras-induced Interleukin-8 Expression Plays a Critical Role in Tumor Growth and Angiogenesis,” Cancer Cell 6, no. 5 (2004): 447-458.

[30] J. Wei, D. T. Baptista-Hon, Z. Wang, et al., “Bioengineered human Tissue Regeneration and Repair Using Endogenous Stem Cells,” Cell Reports Medicine 4, no. 8 (2023): 101156.

[31] C. Cayrol and J. P. Girard, “Interleukin-33 (IL-33): A Nuclear Cytokine From the IL-1 family,” Immunological Reviews 281, no. 1 (2018): 154-168.

[32] C. Yin, B. Liu, Y. Li, et al., “IL-33/ST2 Induces Neutrophil-dependent Reactive Oxygen Species Production and Mediates Gout Pain,” Theranostics 10, no. 26 (2020): 12189-12203.

[33] B. A. Sayed, A. L. Christy, M. E. Walker, and M. A. Brown, “Meningeal Mast Cells Affect Early T Cell central Nervous System Infiltration and Blood-brain Barrier Integrity Through TNF: A Role for Neutrophil Recruitment?,” Journal of Immunology 184, no. 12 (2010): 6891-6900.

[34] K. De Filippo, A. Dudeck, M. Hasenberg, et al., “Mast Cell and Macrophage Chemokines CXCL1/CXCL2 Control the Early Stage of Neutrophil Recruitment During Tissue Inflammation,” Blood 121, no. 24 (2013): 4930-4937.

[35] N. Tosti, E. Cremonesi, V. Governa, et al., “Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer,” Cancer immunology research 8, no. 11 (2020): 1452-1462.

[36] C. Del Fresno, P. Saz-Leal, M. Enamorado, et al., “DNGR-1 in Dendritic Cells Limits Tissue Damage by Dampening Neutrophil Recruitment,” Science 362, no. 6412 (2018): 351-356.

[37] B. Langhans, B. Krämer, M. Louis, et al., “Intrahepatic IL-8 Producing Foxp3⁺CD4⁺ Regulatory T Cells and Fibrogenesis in Chronic hepatitis C,” Journal of Hepatology 59, no. 2 (2013): 229-235.

[38] C. D. Russell, S. A. Unger, M. Walton, and J. Schwarze, “The Human Immune Response to Respiratory Syncytial Virus Infection,” Clinical Microbiology Reviews 30, no. 2 (2017): 481-502.

[39] O. S. Kotsiou, K. I. Gourgoulianis, and S. G. Zarogiannis, “IL-33/ST2 Axis in Organ Fibrosis,” Frontiers in immunology 9 (2018): 2432.

[40] J. Wang, “Neutrophils in Tissue Injury and Repair,” Cell and Tissue Research 371, no. 3 (2018): 531-539.

[41] H. Venugopal, A. Hanna, C. Humeres, and N. G. Frangogiannis, “Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction,” Cells 11, no. 9 (2022).

[42] V. C. Ardi, T. A. Kupriyanova, E. I. Deryugina, and J. P. Quigley, “Human Neutrophils Uniquely Release TIMP-free MMP-9 to Provide a Potent Catalytic Stimulator of Angiogenesis,” PNAS 104, no. 51 (2007): 20262-20267.

[43] A. E. Fetz, M. Z. Radic, and G. L. Bowlin, “Neutrophils in Biomaterial-Guided Tissue Regeneration: Matrix Reprogramming for Angiogenesis,” Tissue Engineering Part B: Reviews 27, no. 2 (2021): 95-106.

[44] A. Warnatsch, M. Ioannou, Q. Wang, and V. Papayannopoulos, “Inflammation. Neutrophil Extracellular Traps License Macrophages for Cytokine Production in Atherosclerosis,” Science 349, no. 6245 (2015): 316-320.

[45] R. S. Apte, D. S. Chen, and N. Ferrara, “VEGF in Signaling and Disease: Beyond Discovery and Development,” Cell 176, no. 6 (2019): 1248-1264.

[46] K. De Bock, M. Georgiadou, S. Schoors, et al., “Role of PFKFB3-Driven Glycolysis in Vessel Sprouting,” Cell 154, no. 3 (2013): 651-663.

[47] G. Parra-Bonilla, D. F. Alvarez, A. B. Al-Mehdi, M. Alexeyev, and T. Stevens, “Critical Role for Lactate Dehydrogenase A in Aerobic Glycolysis That Sustains Pulmonary Microvascular Endothelial Cell Proliferation,” American Journal of Physiology. Lung Cellular and Molecular Physiology 299, no. 4 (2010): L513-22.

[48] K. Peters, G. Kamp, A. Berz, et al., “Changes in human Endothelial Cell Energy Metabolic Capacities During in Vitro Cultivation. The Role of “Aerobic Glycolysis” and Proliferation,” Cellular Physiology and Biochemistry 24, no. 5-6 (2009): 483-492.

[49] W. L. Yeh, C. J. Lin, and W. M. Fu, “Enhancement of Glucose Transporter Expression of Brain Endothelial Cells by Vascular Endothelial Growth Factor Derived From Glioma Exposed to Hypoxia,” Molecular Pharmacology 73, no. 1 (2008): 170-177.

[50] M. Potente and P. Carmeliet, “The Link between Angiogenesis and Endothelial Metabolism,” Annual Review of Physiology 79 (2017): 43-66.

[51] Y. Gong and D.-R. Koh, “Neutrophils Promote Inflammatory Angiogenesis via Release of Preformed VEGF in an in Vivo Corneal Model. Article,” Cell And tissue research 339, no. 2 (2010): 437-448.

[52] S. T. Nillesen, P. J. Geutjes, R. Wismans, J. Schalkwijk, W. F. Daamen, and T. H. van Kuppevelt, “Increased Angiogenesis and Blood Vessel Maturation in Acellular Collagen-heparin Scaffolds Containing both FGF2 and VEGF,” Biomaterials 28, no. 6 (2007): 1123-1131.

[53] Z. G. Fridlender, J. Sun, S. Kim, et al., “Polarization of Tumor-associated Neutrophil Phenotype by TGF-beta: “N1” versus “N2” TAN,” Cancer Cell 16, no. 3 (2009): 183-194.

[54] D. F. Quail, B. Amulic, M. Aziz, et al., “Neutrophil Phenotypes and Functions in Cancer: A Consensus Statement,” Journal of Experimental Medicine 219, no. 6 (2022): e20220011.

[55] L. D. Sansores-Espana, S. Melgar-Rodriguez, R. Vernal, B. A. Carrillo-Avila, V. M. Martinez-Aguilar, and J. Diaz-Zuniga, “Neutrophil N1 and N2 Subsets and Their Possible Association With Periodontitis: A Scoping Review,” International Journal of Molecular Sciences 23, no. 20 (2022): 12068.

[56] N. Borregaard, “Neutrophils, From Marrow to Microbes,” Immunity 33, no. 5 (2010): 657-670.

[57] I. Naegelen, N. Beaume, S. Plançon, V. Schenten, E. J. Tschirhart, and S. Bréchard, “Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting,” Journal of Immunology Research 2015 (2015): 817038.

[58] M. E. Shaul and Z. G. Fridlender, “Neutrophils as Active Regulators of the Immune System in the Tumor Microenvironment,” Journal of Leukocyte Biology 102, no. 2 (2017): 343-349.

[59] Y. Ma, A. Yabluchanskiy, R. P. Iyer, et al., “Temporal Neutrophil Polarization Following Myocardial Infarction,” Cardiovascular Research 110, no. 1 (2016): 51-61.

[60] M. E. Shaul, L. Levy, J. Sun, et al., “Tumor-associated Neutrophils Display a Distinct N1 Profile Following TGFβ Modulation: A Transcriptomics Analysis of Pro- vs. antitumor TANs,” OncoImmunology (7723) 5, no. 11 (2016): e1232221.

[61] M. Ohms, S. Möller, and T. Laskay, “An Attempt to Polarize Human Neutrophils toward N1 and N2 Phenotypes in Vitro,” Frontiers in immunology 11 (2020): 532.

[62] M. Tamari, K. L. Del Bel, A. M. Ver Heul, et al., “Sensory Neurons Promote Immune Homeostasis in the Lung,” Cell 187, no. 1 (2024): 44-61. e17.

[63] N. Gour, H. M. Yong, A. Magesh, et al., “A GPCR-neuropeptide Axis Dampens Hyperactive Neutrophils by Promoting an Alternative-Like Polarization During Bacterial Infection,” Immunity (2024).

[64] J. Yang, Y. Xie, Z. Xia, et al., “HucMSC-Exo Induced N2 Polarization of Neutrophils: Implications for Angiogenesis and Tissue Restoration in Wound Healing,” International Journal of Nanomedicine 19 (2024): 3555-3575.

[65] D. Ye, K. Yang, S. Zang, et al., “Lipocalin-2 Mediates Non-alcoholic Steatohepatitis by Promoting Neutrophil-macrophage Crosstalk via the Induction of CXCR2,” Journal of Hepatology 65, no. 5 (2016): 988-997.

[66] Z. Gao, Y. Yu, K. Dai, et al., “Engineering Neutrophil Immunomodulatory Hydrogels Promoted Angiogenesis,” ACS Applied Materials & Interfaces 14, no. 35 (2022): 39746-39758.

[67] R. Z. Lin, C. N. Lee, R. Moreno-Luna, et al., “Host Non-inflammatory Neutrophils Mediate the Engraftment of Bioengineered Vascular Networks,” Nature Biomedical Engineering (2017): 0081.

[68] S. Massena, G. Christoffersson, E. Vågesjö, et al., “Identification and Characterization of VEGF-A-responsive Neutrophils Expressing CD49d, VEGFR1, and CXCR4 in Mice and Humans,” Blood 126, no. 17 (2015): 2016-2026.

[69] G. Christoffersson, E. Vågesjö, J. Vandooren, et al., “VEGF-A Recruits a Proangiogenic MMP-9-delivering Neutrophil Subset That Induces Angiogenesis in Transplanted Hypoxic Tissue,” Blood 120, no. 23 (2012): 4653-4662.

[70] M. Nishide and A. Kumanogoh, “The Role of Semaphorins in Immune Responses and Autoimmune Rheumatic Diseases,” Nature Reviews Rheumatology 14, no. 1 (2018): 19-31.

[71] M. Nishide, S. Nojima, D. Ito, et al., “Semaphorin 4D Inhibits Neutrophil Activation and Is Involved in the Pathogenesis of Neutrophil-mediated Autoimmune Vasculitis,” Annals of the Rheumatic Diseases 76, no. 8 (2017): 1440-1448.

[72] D. Nakazawa, S. Masuda, U. Tomaru, and A. Ishizu, “Pathogenesis and Therapeutic Interventions for ANCA-associated Vasculitis,” Nature Reviews Rheumatology 15, no. 2 (2019): 91-101.

[73] K. Kessenbrock, M. Krumbholz, U. Schönermarck, et al., “Netting Neutrophils in Autoimmune Small-vessel Vasculitis,” Nature Medicine 15, no. 6 (2009): 623-625.

[74] H. B. Shim, J. F. Deniset, and P. Kubes, “Neutrophils in Homeostasis and Tissue Repair,” International Immunology 34, no. 8 (2022): 399-407.

[75] Y. Dong, Z. Kang, Z. Zhang, et al., “Single-cell Profile Reveals the Landscape of Cardiac Immunity and Identifies a Cardio-protective Ym-1hi Neutrophil in Myocardial Ischemia-reperfusion Injury,” Science Bulletin 69, no. 7 (2024): 949-967.

[76] A. R. Sas, K. S. Carbajal, A. D. Jerome, et al., “A New Neutrophil Subset Promotes CNS Neuron Survival and Axon Regeneration,” Nature Immunology 21, no. 12 (2020): 1496-1505.

[77] A. D. Jerome, A. R. Sas, Y. Wang, et al., “Cytokine Polarized, Alternatively Activated Bone Marrow Neutrophils Drive Axon Regeneration,” Nature Immunology 25, no. 6 (2024): 957-968.

[78] M. Liu, K. Chen, T. Yoshimura, et al., “Formylpeptide Receptors Mediate Rapid Neutrophil Mobilization to Accelerate Wound Healing,” PLoS One 9, no. 6 (2014): e90613.

[79] N. Nishio, Y. Okawa, H. Sakurai, and K.-i. Isobe, “Neutrophil Depletion Delays Wound Repair in Aged Mice. Article,” Age 30, no. 1 (2008): 11-19.

[80] C. W. Tseng and G. Y. Liu, “Expanding Roles of Neutrophils in Aging Hosts,” Current Opinion in Immunology 29 (2014): 43-48.

[81] T. Vicanolo, A. Özcan, J. L. Li, et al., “Matrix-producing Neutrophils Populate and Shield the Skin,” Nature (2025).

[82] S. A. Eming, P. Martin, and M. Tomic-Canic, “Wound Repair and Regeneration: Mechanisms, Signaling, and Translation,” Science Translational Medicine 6, no. 265 (2014): 265sr6.

[83] A. A. Mamun, C. Shao, P. Geng, S. Wang, and J. Xiao, “Recent Advances in Molecular Mechanisms of Skin Wound Healing and Its Treatments,” Frontiers in immunology 15 (2024): 1395479.

[84] V. Papayannopoulos, “Neutrophil Extracellular Traps in Immunity and Disease,” Nature Reviews Immunology 18, no. 2 (2018): 134-147.

[85] H. Lörchner, L. Cañes Esteve, M. E. Góes, et al., “Neutrophils for Revascularization Require Activation of CCR6 and CCL20 by TNFα,” Circulation Research 133, no. 7 (2023): 592-610.

[86] P. St B. Schneider, S. Brickson, D. T. Corr, and T. Best, “CD11b+ neutrophils Predominate Over RAM11+ Macrophages in Stretch-injured Muscle,” Muscle & Nerve 25, no. 6 (2002): 837-844.

[87] I. Kologrivova, M. Shtatolkina, T. Suslova, and V. Ryabov, “Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair after Myocardial Infarction,” Frontiers in Immunology 12 (2021): 664457.

[88] M. Horckmans, L. Ring, J. Duchene, et al., “Neutrophils Orchestrate Post-myocardial Infarction Healing by Polarizing Macrophages towards a Reparative Phenotype,” European Heart Journal 38, no. 3 (2017): 187-197.

[89] H. Lörchner, J. Pöling, P. Gajawada, et al., “Myocardial Healing Requires Reg3β-dependent Accumulation of Macrophages in the Ischemic Heart,” Nature Medicine 21, no. 4 (2015): 353-362.

[90] J. A. Marwick, R. Mills, O. Kay, et al., “Neutrophils Induce Macrophage Anti-inflammatory Reprogramming by Suppressing NF-κB Activation,” Cell Death & Disease 9, no. 6 (2018): 665.

[91] L. Claes, S. Recknagel, and A. Ignatius, “Fracture Healing Under Healthy and Inflammatory Conditions,” Nature Reviews Rheumatology 8, no. 3 (2012): 133-143, Review.

[92] A. Kovtun, D. A. C. Messerer, K. Scharffetter-Kochanek, M. Huber-Lang, and A. Ignatius, “Neutrophils in Tissue Trauma of the Skin, Bone, and Lung: Two Sides of the Same Coin,” Journal of Immunology Research 2018 (2018): 8173983.

[93] A. Kovtun, S. Bergdolt, R. Wiegner, P. Radermacher, M. Huber-Lang, and A. Ignatius, “The Crucial Role of Neutrophil Granulocytes in Bone Fracture Healing,” European Cells & Materials 32 (2016): 152-162.

[94] O. W. Bastian, L. Koenderman, J. Alblas, L. P. Leenen, and T. J. Blokhuis, “Neutrophils Contribute to Fracture Healing by Synthesizing Fibronectin+ Extracellular Matrix Rapidly After Injury,” Clinical Immunology 164 (2016): 78-84.

[95] G. N. Duda, S. Geissler, S. Checa, S. Tsitsilonis, A. Petersen, and K. Schmidt-Bleek, “The Decisive Early Phase of Bone Regeneration,” Nature Reviews Rheumatology 19, no. 2 (2023): 78-95.

[96] A. Herrero-Cervera, O. Soehnlein, and E. Kenne, “Neutrophils in Chronic Inflammatory Diseases,” Cellular & Molecular Immunology 19, no. 2 (2022): 177-191.

[97] J. Wang, M. Hossain, A. Thanabalasuriar, M. Gunzer, C. Meininger, and P. Kubes, “Visualizing the Function and Fate of Neutrophils in Sterile Injury and Repair,” Science (2017): 111-116. - 1095-9203 (Electronic).

[98] D. M. Alvarenga, M. S. Mattos, M. E. Lopes, et al., “Paradoxical Role of Matrix Metalloproteinases in Liver Injury and Regeneration After Sterile Acute Hepatic Failure. Article,” Cells 7, no. 12 (2018): 247.

[99] E. Saijou, Y. Enomoto, M. Matsuda, et al., “Neutrophils Alleviate Fibrosis in the CCl4-induced Mouse Chronic Liver Injury Model,” Hepatol Commun 2, no. 6 (2018): 703-717.

[100] W. Yang, Y. Tao, Y. Wu, et al., “Neutrophils Promote the Development of Reparative Macrophages Mediated by ROS to Orchestrate Liver Repair,” Nature Communications 10, no. 1 (2019): 1076.

[101] Y. Deng, Z. Zhao, M. Sheldon, et al., “LIFR Regulates Cholesterol-driven Bidirectional Hepatocyte-neutrophil Cross-talk to Promote Liver Regeneration,” Nature Metabolism (2024).

[102] S. M. Lawrence, R. Corriden, and V. Nizet, “How Neutrophils Meet Their End,” Trends in Immunology 41, no. 6 (2020): 531-544.

[103] O. Soehnlein and L. Lindbom, “Phagocyte Partnership During the Onset and Resolution of Inflammation. Review,” Nature Reviews Immunology 10, no. 6 (2010): 427-439.

[104] H. R. Jones, C. T. Robb, M. Perretti, and A. G. Rossi, “The Role of Neutrophils in Inflammation Resolution,” Seminars in Immunology 28, no. 2 (2016): 137-145.

[105] K. Miles, D. J. Clarke, W. Lu, et al., “Dying and Necrotic Neutrophils Are Anti-inflammatory Secondary to the Release of Alpha-defensins,” Journal of Immunology 183, no. 3 (2009): 2122-2132.

[106] X. Wang, J. Cai, B. Lin, et al., “GPR34-mediated Sensing of Lysophosphatidylserine Released by Apoptotic Neutrophils Activates Type 3 Innate Lymphoid Cells to Mediate Tissue Repair,” Immunity 54, no. 6 (2021): 1123-1136.

[107] L. Xiao, L. Zhang, C. Guo, et al., “Find Me‘’ and “Eat Me” Signals: Tools to Drive Phagocytic Processes for Modulating Antitumor Immunity,” Chinese Journal of Cancer 44, no. 7 (2024): 791-832.

[108] D. El Kebir and J. G. Filep, “Modulation of Neutrophil Apoptosis and the Resolution of Inflammation Through β2 Integrins,” Frontiers in Immunology 4 (2013): 60.

[109] M. R. Elliott and K. S. Ravichandran, “Clearance of Apoptotic Cells: Implications in Health and Disease,” The Journal of Cell Biology 189, no. 7 (2010): 1059-1070.

[110] S. Fox, A. E. Leitch, R. Duffin, C. Haslett, and A. G. Rossi, “Neutrophil Apoptosis: Relevance to the Innate Immune Response and Inflammatory Disease,” Journal of Innate Immunity 2, no. 3 (2010): 216-227.

[111] A. Bogoslowski, S. Wijeyesinghe, W. Y. Lee, et al., “Neutrophils Recirculate Through Lymph Nodes to Survey Tissues for Pathogens,” Journal of Immunology 204, no. 9 (2020): 2552-2561.

[112] M. Vono, A. Lin, A. Norrby-Teglund, R. A. Koup, F. Liang, and K. Loré, “Neutrophils Acquire the Capacity for Antigen Presentation to Memory CD4(+) T Cells in Vitro and Ex Vivo,” Blood 129, no. 14 (2017): 1991-2001.

[113] S. Bennouna, S. K. Bliss, T. J. Curiel, and E. Y. Denkers, “Cross-talk in the Innate Immune System: Neutrophils Instruct Recruitment and Activation of Dendritic Cells During Microbial Infection,” Journal of Immunology 171, no. 11 (2003): 6052-6058.

[114] K. P. van Gisbergen, M. Sanchez-Hernandez, T. B. Geijtenbeek, and Y. van Kooyk, “Neutrophils Mediate Immune Modulation of Dendritic Cells Through Glycosylation-dependent Interactions Between Mac-1 and DC-SIGN,” The Journal of Experimental Medicine 201, no. 8 (2005): 1281-1292.

[115] B. Ferraro, G. Leoni, R. Hinkel, et al., “Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair,” Journal of the American College of Cardiology 73, no. 23 (2019): 2990-3002.

[116] A. Bhattacharya, Q. Wei, J. N. Shin, et al., “Autophagy Is Required for Neutrophil-Mediated Inflammation,” Cell Reports 12, no. 11 (2015): 1731-1739.

[117] M. A. Delgado and V. Deretic, “Toll-Like Receptors in Control of Immunological Autophagy,” Cell Death and Differentiation 16, no. 7 (2009): 976-983.

[118] I. Mitroulis, I. Kourtzelis, K. Kambas, et al., “Regulation of the Autophagic Machinery in human Neutrophils,” European Journal of Immunology 40, no. 5 (2010): 1461-1472.

[119] P. Skendros, I. Mitroulis, and K. Ritis, “Autophagy in Neutrophils: From Granulopoiesis to Neutrophil Extracellular Traps,” Frontiers in Cell and Developmental Biology 6 (2018): 109.

[120] N. Germic, D. Stojkov, K. Oberson, S. Yousefi, and S. HU, “Neither Eosinophils nor Neutrophils Require ATG5-dependent Autophagy for Extracellular DNA Trap Formation,” Immunology 152, no. 3 (2017): 517-525.

[121] W. Loh and S. Vermeren, “Anti-Inflammatory Neutrophil Functions in the Resolution of Inflammation and Tissue Repair,” Cells 11, no. 24 (2022).

[122] S. Nagata and P. Golstein, “The Fas Death Factor,” Science 267, no. 5203 (1995): 1449-1456.

[123] S. Hashimoto, M. Setareh, R. L. Ochs, and M. Lotz, “Fas/Fas Ligand Expression and Induction of Apoptosis in Chondrocytes,” Arthritis and Rheumatism 40, no. 10 (1997): 1749-1755.

[124] X. Wang, Z. He, H. Liu, S. Yousefi, and S. HU, “Neutrophil Necroptosis Is Triggered by Ligation of Adhesion Molecules Following GM-CSF Priming,” Journal of Immunology 197, no. 10 (2016): 4090-4100.

[125] X. Wang, S. Yousefi, and S. HU, “Necroptosis and Neutrophil-associated Disorders,” Cell Death & Disease 9, no. 2 (2018): 111.

[126] J. Desai, S. R. Mulay, D. Nakazawa, and H. J. Anders, “Matters of Life and Death. How Neutrophils Die or Survive Along NET Release and Is “NETosis” = Necroptosis?,” Cellular and Molecular Life Sciences: CMLS 73, no. 11-12 (2016): 2211-2219.

[127] E. Pérez-Figueroa, P. Álvarez-Carrasco, E. Ortega, and C. Maldonado-Bernal, “Neutrophils: Many Ways to Die,” Frontiers in Immunology 12 (2021): 631821.

[128] G. R. Dubyak, B. A. Miller, and E. Pearlman, “Pyroptosis in Neutrophils: Multimodal Integration of Inflammasome and Regulated Cell Death Signaling Pathways,” Immunological Reviews 314, no. 1 (2023): 229-249.

[129] J. C. Ryu, M. J. Kim, Y. Kwon, et al., “Neutrophil Pyroptosis Mediates Pathology of P. aeruginosa Lung Infection in the Absence of the NADPH Oxidase NOX2,” Mucosal Immunology 10, no. 3 (2017): 757-774.

[130] L. Liu and B. Sun, “Neutrophil Pyroptosis: New Perspectives on Sepsis,” Cellular and Molecular Life Sciences: CMLS 76, no. 11 (2019): 2031-2042.

[131] F. Ma, L. Ghimire, Q. Ren, et al., “Gasdermin E Dictates Inflammatory Responses by Controlling the Mode of Neutrophil Death,” Nature Communications 15, no. 1 (2024): 386.

[132] C. M. de Bont, W. C. Boelens, and G. J. M. Pruijn, “NETosis, Complement, and Coagulation: A Triangular Relationship,” Cellular & Molecular Immunology 16, no. 1 (2019): 19-27.

[133] B. McDonald, R. P. Davis, S. J. Kim, et al., “Platelets and Neutrophil Extracellular Traps Collaborate to Promote Intravascular Coagulation During Sepsis in Mice,” Blood 129, no. 10 (2017): 1357-1367.

[134] A. E. Fetz and G. L. Bowlin, “Neutrophil Extracellular Traps: Inflammation and Biomaterial Preconditioning for Tissue Engineering,” Tissue Engineering Part B-Reviews 28, no. 2 (2022): 437-450.

[135] T. A. Fuchs, A. Brill, D. Duerschmied, et al., “Extracellular DNA Traps Promote Thrombosis,” PNAS 107, no. 36 (2010): 15880-15885.

[136] C. A. Dorsch, “Binding of Single-strand DNA to human Platelets,” Thrombosis Research 24, no. 1-2 (1981): 119-129.

[137] F. Semeraro, C. T. Ammollo, J. H. Morrissey, et al., “Extracellular Histones Promote Thrombin Generation Through Platelet-dependent Mechanisms: Involvement of Platelet TLR2 and TLR4,” Blood 118, no. 7 (2011): 1952-1961.

[138] M. J. Shen, K. Jiao, C. Y. Wang, et al., “Extracellular DNA: A Missing Link in the Pathogenesis of Ectopic Mineralization,” Advanced Science 9, no. 5 (2022): e2103693.

[139] J. Pillay, I. den Braber, N. Vrisekoop, et al., “In Vivo Labeling With 2H2O Reveals a human Neutrophil Lifespan of 5.4 Days,” Blood 116, no. 4 (2010): 625-627.

[140] J. Wang, M. Hossain, A. Thanabalasuriar, M. Gunzer, C. Meininger, and P. Kubes, “Visualizing the Function and Fate of Neutrophils in Sterile Injury and Repair,” Science 358, no. 6359 (2017): 111-116.

[141] J. Hughes, R. J. Johnson, A. Mooney, C. Hugo, K. Gordon, and J. Savill, “Neutrophil Fate in Experimental Glomerular Capillary Injury in the Rat. Emigration Exceeds in Situ Clearance by Apoptosis,” The American Journal of Pathology 150, no. 1 (1997): 223-234.

[142] A. Marki and K. Ley, “Leaking Chemokines Confuse Neutrophils,” Journal of Clinical Investigation 130, no. 5 (2020): 2177-2179.

[143] C. D. Buckley, E. A. Ross, H. M. McGettrick, et al., “Identification of a Phenotypically and Functionally Distinct Population of Long-lived Neutrophils in a Model of Reverse Endothelial Migration,” Journal of Leukocyte Biology 79, no. 2 (2006): 303-311.

[144] S. Tauzin, T. W. Starnes, F. B. Becker, P. Y. Lam, and A. Huttenlocher, “Redox and Src family Kinase Signaling Control Leukocyte Wound Attraction and Neutrophil Reverse Migration,” Journal of Cell Biology 207, no. 5 (2014): 589-598.

[145] C. A. Loynes, J. A. Lee, A. L. Robertson, et al., “PGE2 production at Sites of Tissue Injury Promotes an Anti-inflammatory Neutrophil Phenotype and Determines the Outcome of Inflammation Resolution in Vivo,” Science Advances 4, no. 9 (2018): eaar8320.

[146] S. Nourshargh, S. A. Renshaw, and B. A. Imhof, “Reverse Migration of Neutrophils: Where, When, How, and Why?,” Trends in Immunology 37, no. 5 (2016): 273-286.

[147] J. R. Mathias, B. J. Perrin, T. X. Liu, J. Kanki, A. T. Look, and A. Huttenlocher, “Resolution of Inflammation by Retrograde Chemotaxis of Neutrophils in Transgenic Zebrafish,” Journal of Leukocyte Biology 80, no. 6 (2006): 1281-1288.

[148] B. M. Balog, J. P. Niemi, T. Disabato, F. Hashim, and R. E. Zigmond, “CXCR2 mediated Trafficking of Neutrophils and Neutrophil Extracellular Traps Are Required for Myelin Clearance After a Peripheral Nerve Injury,” Experimental Neurology 382 (2024): 114985.

[149] B. M. Balog, A. Sonti, and R. E. Zigmond, “Neutrophil Biology in Injuries and Diseases of the central and Peripheral Nervous Systems,” Progress in Neurobiology 228 (2023): 102488.

[150] A. Aroca-Crevillén, J. M. Adrover, and A. Hidalgo, “Circadian Features of Neutrophil Biology,” Frontiers in immunology 11 (2020): 576.

[151] J. M. Adrover, C. Del Fresno, G. Crainiciuc, et al., “A Neutrophil Timer Coordinates Immune Defense and Vascular Protection,” Immunity 50, no. 2 (2019): 390-402.

[152] W. He, S. Holtkamp, S. M. Hergenhan, et al., “Circadian Expression of Migratory Factors Establishes Lineage-Specific Signatures That Guide the Homing of Leukocyte Subsets to Tissues,” Immunity 49, no. 6 (2018): 1175-1190.

[153] H. Adachi, I. Kubota, N. Okamura, et al., “Purification and Characterization of Human Microsomal Dipeptidase,” The Journal of Biochemistry 105, no. 6 (1989): 957-961.

[154] T. Kawasaki and T. Kawai, “Toll-Like Receptor Signaling Pathways,” Frontiers in immunology 5 (2014): 461.

[155] J. Fu and H. Wu, “Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation,” Annual Review of Immunology 41 (2023): 301-316.

[156] U. H. Lerner, E. Persson, and P. Lundberg. Chapter 47 - Kinins and Neuro-osteogenic Factors. In: Bilezikian JP, Raisz LG, Martin TJ, eds. “Principles of Bone Biology”. (Third Edition). (Academic Press, 2008): 1025-1057. In.

[157] X. Dong, S.-k Han, M. J. Zylka, M. I. Simon, and D. J. Anderson, “A Diverse Family of GPCRs Expressed in Specific Subsets of Nociceptive Sensory Neurons,” Cell 106, no. 5 (2001): 619-632.

[158] J. Meixiong and X. Dong, “Mas-Related G Protein-Coupled Receptors and the Biology of Itch Sensation,” Annual Review of Genetics 51 (2017): 103-121, Volume 51.

[159] J. Meixiong, C. Vasavda, D. Green, et al., “Identification of a Bilirubin Receptor That May Mediate a Component of Cholestatic Itch,” Elife 8 (2019): e44116.

[160] H. Y. Yang, W. Fratta, E. A. Majane, and E. Costa, “Isolation, Sequencing, Synthesis, and Pharmacological Characterization of Two Brain Neuropeptides That Modulate the Action of Morphine,” Proceedings of the National Academy of Sciences 82, no. 22 (1985): 7757-7761.

[161] F. Shojaei, X. Wu, C. Zhong, et al., “Bv8 regulates Myeloid-cell-dependent Tumour Angiogenesis,” Nature 450, no. 7171 (2007): 825-831.

[162] J. R. Sierra, S. Corso, L. Caione, et al., “Tumor Angiogenesis and Progression Are Enhanced by Sema4D Produced by Tumor-associated Macrophages,” Journal of Experimental Medicine 205, no. 7 (2008): 1673-1685.

[163] K. Romejko, M. Markowska, and S. Niemczyk, “The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL),” International Journal of Molecular Sciences 24, no. 13 (2023): 10470.

[164] T. Kubin, J. Pöling, S. Kostin, et al., “Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling,” Cell Stem Cell 9, no. 5 (2011): 420-432.

[165] Y. Wei, B. Lan, T. Zheng, et al., “GSDME-mediated Pyroptosis Promotes the Progression and Associated Inflammation of Atherosclerosis,” Nature Communications 14, no. 1 (2023): 929.

[166] Y. Huang, J. Yang, Y. Zhang, S. Kuang, Z. Shen, and W. Qin, “Blocking CXCR1/2 Attenuates Experimental Periodontitis by Suppressing Neutrophils Recruitment,” International Immunopharmacology 128 (2024): 111465.

[167] R. F. van Vollenhoven, B. H. Hahn, G. C. Tsokos, et al., “Efficacy and Safety of ustekinumab, an IL-12 and IL-23 Inhibitor, in Patients With Active Systemic Lupus Erythematosus: Results of a Multicentre, Double-blind, Phase 2, Randomised, Controlled Study,” Lancet 202731 392, no. 10155 (2018): 1330-1339.

[168] J. S. Smolen, R. B. M. Landewé, S. A. Bergstra, et al., “EULAR Recommendations for the Management of Rheumatoid Arthritis With Synthetic and Biological Disease-modifying Antirheumatic Drugs: 2022 Update,” Annals of the Rheumatic Diseases 82, no. 1 (2023): 3-18.

[169] C. Li, X. Wu, S. Liu, D. Shen, J. Zhu, and K. Liu, “Role of Resolvins in the Inflammatory Resolution of Neurological Diseases,” Frontiers in pharmacology 11 (2020): 612.

[170] J. J. Chmielinska, J. H. Kramer, I. T. Mak, C. F. Spurney, and W. B Weglicki, “Substance P Receptor Blocker, Aprepitant, Inhibited Cutaneous and Other Neurogenic Inflammation Side Effects of the EGFR1-TKI, Erlotinib,” Molecular and Cellular Biochemistry 2020; 465(1-2): 175-185.

[171] D. J. Kim, J. Y. Moon, S. M. Kim, et al., “Substance P Improves Renal Ischemia Reperfusion Injury through Modulating Immune Response,” Frontiers in immunology 11 (2020): 600.

[172] A. Mohammad, F. Babiker, and M. Al-Bader, “Effects of Apocynin, a NADPH Oxidase Inhibitor, in the Protection of the Heart From Ischemia/Reperfusion Injury,” Pharmaceuticals 16, no. 4 (2023).

[173] T. Zhang, Y. Mei, W. Dong, J. Wang, F. Huang, and J. Wu, “Evaluation of Protein Arginine Deiminase-4 Inhibitor in TNBS- induced Colitis in Mice,” International Immunopharmacology 84 (2020): 106583.

[174] C. Kim, H. Kim, W.-S. Sim, et al., “Spatiotemporal Control of Neutrophil Fate to Tune Inflammation and Repair for Myocardial Infarction Therapy,” Nature Communications 15, no. 1 (2024): 8481.

[175] S. Kumaran Satyanarayanan, D. El Kebir, S. Soboh, et al., “IFN-β Is a Macrophage-derived Effector Cytokine Facilitating the Resolution of Bacterial Inflammation,” Nature Communications 10, no. 1 (2019): 3471.

[176] T. Nguyen, E. K. Deenick, and S. G. Tangye, “Phosphatidylinositol 3-kinase Signaling and Immune Regulation: Insights Into Disease Pathogenesis and Clinical Implications,” Expert Review of Clinical Immunology 17, no. 8 (2021): 905-914.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.